| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 29 May 2025 | 23 May 2025 |
| Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve (1)The Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and financial year ended 31st March 2025; & 2) Raising of funds as mentioned in the attached intimation. Pursuant to SEBI Listing Regulations, 2015, Please find enclosed herewith the Outcome of the Board Meeting held today i.e. 29th May, 2025, along with the Audited Standalone and Consolidated financial results for the quarter and year ended 31st March, 2025. Pursuant to Regulation 30 of SEBI Listing Regulations, 2015, Please find enclosed herewith the Outcome of the Board Meeting held today, i.e. 29th May, 2025 along with the Audited Standalone and Consolidated Financial Results. Pursuant to Regulation 30 of SEBI Listing Regulation, 2015, Please find enclosed herewith disclosure in respect of 1) Re-appointment of Mr. Akhilesh Krishna Gupta, Independent Director; and 2) Appointment of Mr. Virendra G. Bhatt as Secretarial Auditor of the Company. (As Per BSE Announcement Dated on 29.05.2025) | ||
| Board Meeting | 7 Feb 2025 | 3 Feb 2025 |
| WOCKHARDT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and is closure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday 7th February 2025 inter-alia to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December 2024. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations); and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2024-25/086 dated 3rd February, 2025, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 7th February, 2025, inter-alia, have approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2024. (As Per BSE Announcement Dated on: 07/02/2025) | ||
| Board Meeting | 13 Nov 2024 | 8 Nov 2024 |
| WOCKHARDT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 13th November 2024 inter-alia to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the half year ended 30th September 2024. In view of the above the trading window for dealing in the shares of the Company which was closed from Tuesday 1st October 2024 shall remain closed until 48 hours after the declaration of financial results on 13th November 2024. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we enclose herewith Unaudited Financial Results for the quarter and half year .... Read More.. (As Per BSE Announcement Dated on 13.11.2024) | ||
| Board Meeting | 9 Aug 2024 | 5 Aug 2024 |
| WOCKHARDT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday 9th August 2024 inter-alia to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2024. Pursuant to Regulation 30 of SEBI LODR Regulations, 2015 , we wish to inform that the Board of Directors at its meeting held today i.e. 9th August, 2024 have approved the appointment of Mr. Paresh Kajrolkar, Head of the Internal Audit, based on the recommendation of Audit Committee as Internal Auditor of the Company w.e.f. 9th August, 2024. Pursuant to Regulations 30 of SEBI LODR Regulations, 2015 and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2024-25/032 dated 5th August, 2024, we wish to inform .... Read More.. Pursuant to Regulations 30 of SEBI LODR Regulations, 2015 and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2024-25/032 dated 5th August, 2024, we wish to inform .... Read More.. (As per BSE Announcement Dated on 09/08/2024) | ||
WCK 6777 is the only once-a-day antibiotic in the global pipeline designated for outpatient parenteral antimicrobial therapy (OPAT).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
